Medex Announces Second Quarter 2004 Earnings Call

CARLSBAD, Calif., Aug. 3 /PRNewswire/ -- Medex, Inc. has announced an intent to file its Quarterly Report on Form 10-Q for the quarter and six months ended June 26, 2004 with the Securities and Exchange Commission on Tuesday, August 10, 2004.

A conference call is scheduled for Thursday, August 12 at 4:30pm EDT. Dominick Arena, President and Chief Executive Officer, and Michael Dobrovic, Chief Financial Officer, will be hosting the call to discuss details regarding company performance for the quarter and six months ended June 26, 2004.

Individuals wishing to participate in this call should dial (888) 455-5419 or (712) 257-2022; the passcode is MEDEX. This call will be recorded, with an electronic transcript furnished upon request. Individuals interested in obtaining replay instructions or a transcript should either contact Gregory Aranaga at (760) 602-4455 or visit

About Medex

Medex is a global manufacturer and distributor of critical care medical products used primarily in acute care settings for a variety of both therapeutic and diagnostic procedures. Medex markets and sells critical care systems and products to over 5,500 hospitals, health care systems, and alternate healthcare settings in more than 75 countries through a global sales force and distribution network. Headquartered in Carlsbad, California, the company employs approximately 2,000 people worldwide.

For more information, please visit Forward-Looking Statements

This news release contains certain "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are predictive in nature, that depend upon or refer to future events or conditions or that include words such as "expects," "anticipates," "intends," "plans," "believes," "estimates," and similar expressions are forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results and performance to be materially different from any future results or performance expressed or implied by these forward-looking statements. Detailed information about such risk factors is set forth in the Registration Statement on Form S-4 filed by Medex with the Securities and Exchange Commission on April 7, 2004 including, but not limited to, those risks and uncertainties listed in the section entitled "Management's Discussion and Analysis of Financial Condition and Results of Operations." Medex undertakes no obligation to update, alter or release publicly any revisions to its forward-looking statements, whether as a result of new information, subsequent events or developments.

For more information, please contact Gregory Aranaga, Director, Corporate Communications of Medex, Inc., +1-760-602-4455,

Medex, Inc.

CONTACT: Gregory Aranaga, Director, Corporate Communications ofMedex, Inc., +1-760-602-4455,

Back to news